CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...